Salivary MicroRNA in Endometriosis: Correlation With Progestin Treatment Response: A Prospective Observational Study
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
This study aims to analyze the salivary miRNA specific for patients diagnosed with endometriosis, specifically evaluating the miRNA profile of patients who respond versus those who do not respond to progestin therapy. Ninety patients attending the Chronic Pelvic Pain Clinic will be recruited, and they will be asked to provide a saliva sample before starting medical therapy. The response to the therapy will be evaluated after 4 months from the beginning of the therapy itself.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:
• Age \> 18 years
• Fertile age
• Clinical-ultrasound diagnosis or histological diagnosis of endometriosis
• Informed consent
Locations
Other Locations
Italy
University of Udine
RECRUITING
Udine
Contact Information
Primary
Matilde Degano, dr
matildedegano@rocketmail.com
3206173076
Backup
Anna Biasioli, dr
anna.biasioli@asufc.sanita.fvg.it
Time Frame
Start Date: 2024-04-22
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 90
Treatments
Endometriosis patients
Patients diagnosed with endometriosis attending the Obstetrics and Gynecology Clinic at the Santa Maria della Misericordia Hospital in Udine, who have not yet started medical therapy.
Related Therapeutic Areas
Sponsors
Leads: University of Udine